AVITA Medical Inc
NASDAQ:RCEL
AVITA Medical Inc
Other Operating Expenses
AVITA Medical Inc
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AVITA Medical Inc
NASDAQ:RCEL
|
Other Operating Expenses
$1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Operating Expenses
$169m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Operating Expenses
-$791m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Operating Expenses
$49.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Operating Expenses
-$13.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AVITA Medical Inc's Other Operating Expenses?
Other Operating Expenses
1.4m
USD
Based on the financial report for Dec 31, 2023, AVITA Medical Inc's Other Operating Expenses amounts to 1.4m USD.
What is AVITA Medical Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
-56%
Over the last year, the Other Operating Expenses growth was -56%.